Centre Hospitalier Universitaire Dijon
Clinical trials sponsored by Centre Hospitalier Universitaire Dijon, explained in plain language.
-
Sedative tested as lifeline for deadly shock patients
Disease control TerminatedThis study tested whether adding a sedative drug called dexmedetomidine could help patients with severe septic shock, a life-threatening condition where blood pressure drops dangerously low and doesn't respond to standard medications. The goal was to see if this drug could improv…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Can better dental care improve life for schizophrenia patients?
Disease control TerminatedThis study tested whether a 6-month dental health education program could improve oral hygiene and quality of life for people with schizophrenia. The program taught patients about dental care and was compared to standard monitoring. Researchers followed 79 patients for 12 months …
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Eye injection trial for rare vision disease halted early
Disease control TerminatedThis study tested whether aflibercept eye injections could reduce swelling in the retina caused by a rare eye disease called Macular Telangiectasia Type 1. It was a Phase 3 trial that planned to compare the drug against a placebo injection in 16 participants over 6 months. The tr…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Drug trial aims to ease patients off Life-Support machines
Disease control TerminatedThis study tested whether a drug called levosimendan could help patients with severe heart failure safely stop using a temporary heart-lung machine (ECLS). The drug is meant to strengthen the heart's pumping ability. Researchers compared the drug to a placebo in 82 patients to se…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Diabetes drug trial aims to shrink dangerous liver fat
Disease control TerminatedThis study tested if liraglutide, a medication for type 2 diabetes, could reduce fat buildup in the liver and improve cholesterol levels. It involved 127 adults with type 2 diabetes who took the drug for six months. Researchers used special scans and blood tests to measure change…
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
Race against time: does starting dialysis earlier save lives in septic shock?
Disease control TerminatedThis study aimed to find out if starting dialysis treatment early or waiting a bit longer leads to better survival for ICU patients with septic shock and sudden, severe kidney failure. It involved 500 critically ill adults and directly compared starting dialysis within 12 hours v…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
One shot before surgery could slash dangerous infections
Disease control TerminatedThis study tested whether giving a single dose of a steroid (methylprednisolone) right before elective colon or rectal surgery could reduce serious complications afterward. It involved 78 adults having planned surgery for conditions like cancer or diverticulitis. The goal was to …
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Early trial halted for rare 'Overgrowth' disease
Disease control TerminatedThis early-phase trial tested a drug called taselisib in people with rare, often severe, genetic overgrowth conditions. The goal was to see if the drug, which targets a specific genetic mutation, could safely control the abnormal tissue growth. The study was small and terminated …
Phase: PHASE1, PHASE2 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Mar 16, 2026 15:23 UTC
-
Can meditation calm the stressed Caregiver's body and mind?
Symptom relief TerminatedThis study tested whether a mindfulness meditation program could help reduce stress and related body inflammation in people caring for family members with severe psychiatric disorders like schizophrenia or bipolar disorder. Caregivers were randomly assigned to either attend mindf…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Symptom relief
Last updated Mar 11, 2026 14:53 UTC
-
Searching for Cancer's secret messages in the bloodstream
Knowledge-focused TerminatedThis study aimed to find new ways to predict how colorectal cancer will progress by looking at tiny particles called exosomes in the blood. Researchers analyzed stored blood samples from 172 patients to see if specific markers within these particles could indicate a patient's sur…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC
-
Scientists probe if diabetes drug changes what you crave
Knowledge-focused TerminatedThis study aimed to understand how the diabetes medication liraglutide (Victoza®) changes eating behavior in people with type 2 diabetes. Researchers compared three groups: patients starting the drug, similar patients not on the drug, and healthy volunteers. They measured changes…
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Could your personality affect your diabetes?
Knowledge-focused TerminatedThis study aimed to understand if a person's personality type is linked to biological signs of stress and aging in people with diabetes. Researchers compared 'impatient' (Type A) and 'calm' (Type B) individuals by asking questions and taking a single blood sample. The goal was to…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC
-
Cancer Drug's hidden heart danger under investigation
Knowledge-focused TerminatedThis study aimed to better understand and detect heart complications, particularly irregular heartbeat (atrial fibrillation), in cancer patients taking the medication ibrutinib. It followed a small group of 8 patients starting ibrutinib treatment, using special tests to try to pr…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC
-
Can a simple score tell you how well You'll see after eye surgery?
Knowledge-focused TerminatedThis study aimed to test a new scoring system that predicts how well a patient's vision will recover one year after a combined eye surgery. The surgery removes both a cataract and a thin scar tissue (epiretinal membrane) from the retina. Researchers tested the score on patients t…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC
-
Breathing machine damage: scientists probe hidden cell harm in lungs
Knowledge-focused TerminatedThis study aimed to understand how mechanical ventilators (breathing machines) might damage the energy-producing parts of immune cells in the lungs of patients with severe pneumonia and breathing failure. Researchers planned to compare cells from 28 patients on ventilators with t…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC
-
New scanner could help doctors predict amputation recovery
Knowledge-focused TerminatedThis study tested a special light scanner (NIRS) to see if it could better predict how well a leg stump heals after amputation. It involved 62 people who had a below-the-knee amputation due to poor circulation. Researchers compared the new scanner to the current standard method t…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC